Strata Critical Medical, Inc.
SRTA
$5.43
-$0.06-1.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 124.39% | -115.38% | 1,633.96% | -7.16% | 64.33% |
| Total Depreciation and Amortization | 1.73% | 76.53% | -4.05% | 4.66% | 58.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.41% | 108.98% | -2,255.77% | 492.05% | -87.86% |
| Change in Net Operating Assets | 87.54% | -248.48% | 234.46% | -911.48% | 218.26% |
| Cash from Operations | 146.77% | 77.73% | -1,117.27% | -1,145.53% | 85.96% |
| Capital Expenditure | -180.25% | 36.23% | -25.78% | 11.86% | 42.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 97.91% | -- | -- | -- |
| Divestitures | 81.52% | -26.43% | -- | -- | -- |
| Other Investing Activities | 31.05% | -67.87% | 131.96% | 34.29% | 169.19% |
| Cash from Investing | 35.39% | 661.68% | -91.64% | 40.54% | 413.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -3.70% | -16.92% | 364.29% | -76.67% | 36.36% |
| Repurchase of Common Stock | 67.59% | 3.02% | -60.90% | 73.27% | -9.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.69% | 2.52% | -57.17% | 73.22% | -9.60% |
| Foreign Exchange rate Adjustments | -- | 100.00% | -507.95% | 19.84% | 215.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 237.82% | 122.03% | -251.45% | 53.54% | 1,011.94% |